Skip to main content Skip to navigation

Lazaros Andronis

Job Title
Associate Professor Reader
Department
WMS - Warwick Clinical Trials Unit
Phone
02476574490
Research Interests

Dr Lazaros Andronis is a Reader in Health Economics and a Senior Member of the Centre for Health Economics at Warwick (CHEW).

Dr Andronis' work draws on social sciences and health care research methods to answer economic questions about health and health care. Within this context, much of his research focuses on the methods and use of economic evaluation as a means of informing the allocation of limited resources across health care programmes, policies, treatments or technologies.

Dr Andronis has published his research in front-line health economics and medical journals, including Social Science and Medicine, Medical Decision Making, PharmacoEconomics, Quality of Life Research, European Journal of Health Economics, JAMA Oncology, Health Technology Assessment, British Medical Journal and he has authored monographs and reports commissioned by national bodies of international significance. He regularly presents his work at major health economics conferences, including meetings of the International Health Economics Association, European Health Economics Association and Health Economists' Study Group.

In 2021, Dr Andronis was awarded an NIHR Advanced Fellowship, a prestigious award that aims to support the development of researchers into international leaders. As part of his Fellowship, Dr Andronis leads a multidisciplinary team of collaborators to explore how best to identify the value that children and young persons place on their time and how to include this in health economic evaluations.

In addition to his NIHR Fellowship, Dr Andronis currently leads or collaborates in the following ongoing projects.

  • EPICE/SHIPS. A large multinational study aiming to understand the socioeconomic determinants, the health care needs and the existing framework of care available to children born very prematurely across 11 EU states, with a view to establishing how resources can be allocated efficiently to support and promote children's health and wellbeing. Funded by the European Union's Horizon 2020 programme.
  • BISTRO. Evaluation of the clinical and cost-effectiveness of bioimpedance analysis for fluid management in dialysis patients. PI: Prof S. Davies (Keele University). Funded by NIHR HTA. Grant value: £1,420,988.
  • ROSSINI II. Evaluation of the cost-effectiveness of several novel surgical interventions aiming to reduce surgical site infection. PI: Prof T. Pinkney (University of Birmingham). Funded by NIHR HTA. Grant value: £1,587,200
  • RECEDE. Evaluation of the effectiveness and cost-effectiveness of dual testing as a means of reducing colonoscopies in those without bowel disease. PI: Prof R. Arasaradnam (University Hospital Coventry and Warwickshire). NIHR Health Services & Delivery Research. Grant value: £894,409
  • PAD optimization. Optimising the deployment of automated external defibrillators in public places in England. PI: Prof G. Perkins (University of Warwick). Funded by NIHR Health Services & Delivery Research. Grant value: £477.177.

In the past, as part of his role in Warwick Evidence, Dr Andronis led Evidence Review Groups commissioned by the National Institute for Health and Care Excellence to appraise the economic evidence submitted in support of treatment reimbursement and availability in the NHS. In this role, Dr Andronis co-ordinated multidisciplinary teams made up of health economists, information specialists, clinical experts and systematic reviewers in appraising evidence and advising NICE on the cost-effectiveness of health care technologies and programmes.

Teaching

Dr Andronis is the Director of Teaching at Centre for Health Economics at Warwick. He co-ordinates the Centre's teaching activities and he plans and leads its agenda.

Dr Andronis teaches health economics to undergraduate and graduate students at Warwick Medical School and the Department of Economics. He is a Fellow of the Higher Education Academy (FHEA), a Fellow of the Warwick International Higher Education Academy (WIHEA) and a member of the WMS Academic Consultation and Advisory Panel for teaching.

In 2020, Dr Andronis was a winner of the Warwick Award for Teaching Excellence, an award that recognises outstanding contribution and leadership in education and teaching.

Supervision

Dr Andronis supervises research projects, including undergraduate and postgraduate final projects and dissertations at Warwick Medical School and the Department of Economics. He has supervised over 40 MSc dissertations, a number of which led to conference presentations and publications in health economics journals. Dr Andronis is currently supervising PhD projects on optimisation of emergency services in low income settings and on patterns of healthcare service demand and utilisation by older people in China.

Biography

Dr Andronis joined the University of Warwick in July 2017, as a Senior Research Fellow in Health Economics. Before his appointment at Warwick, Dr Andronis held the posts of Research Fellow (2006-2009), NIHR Doctoral Research Fellow (2009-2012) and Lecturer in Health Economics (2012-2017) at the Health Economics Unit of the University of Birmingham.

Over the last 10 years, Dr Andronis has been involved in designing, coordinating and conducting methodological and applied health economics research funded by various national bodies, including NICE, NIHR and MRC. He has secured grants worth of over £10 million (as co-applicant) and £900,000 in personal awards (as principal investigator).

Other roles and collegial contributions include:

  • Co-founder and co-lead convener: International Health Economics Association Special Interest Group in Economics of Children's Health and Wellbeing (2020 to date).
  • Funding panel member: NIHR Research for Patient Benefit (RfPB) North West Panel member (2017 to date).
  • Funding panel member: NIHR Pre-Doctoral Fellowships (2022 to date).
  • Funding committee member: NIHR Incubator Selection Committee (2022 to date).
  • NIHR Academy Member (2021- to date) and NIHR Faculty Member (2009-2012).
  • Editorial Panel Member: Medical Decision Making (2017 to date).
  • Scientific Committee Member: International Health Economics Association (iHEA) Congresses (2017 to date)
  • Fellow of the Higher Education Academy (2019 to date)
  • Fellow of the Warwick International Higher Education Academy (2020 to date)
  • Associate Fellow of the Warwick Institute of Engagement (2022 to date)
  • Panel member: WMS Academic Consultation and Advisory Panel (2019 to date)
Title Funder Award start Award end
NIHR Advanced Fellowship: Estimating the value of children's time for use in economic evaluation National Institute for Health Research (NIHR DoH) 01 Feb 2022 31 Jan 2026
NIHR HS&DR Stage 2 Lead by UHCW:Single use versus multiple use endoscopes: balancing infection control and environmental impact (SUMU-Endo) National Institute for Health Research (NIHR DoH) 01 Jun 2023 31 May 2025
NIHR HS&DR:Costed extension for RECEDE Study-linked to IDEATE 62694 National Institute for Health Research (NIHR DoH) 01 Nov 2022 31 Oct 2023
No cost extension to BioImpedance Spectroscopy to Maintain Renal Output: The BISTRO Trial (Ideate 57025) National Institute for Health Research (NIHR DoH) 01 Feb 2022 31 Jul 2023
RECEDE study (Reducing Colonoscopies in those without bowEl DiseasE) HS&DR Stage 2 (Stage 1 - 60439) National Institute for Health Research (DoH) 01 May 2020 31 Oct 2022
NIHR HS&DR Full Stage: Optimisation of the Deployment of Automated External Defibrillators in Public Places in England National Institute for Health Research (DoH) 01 Oct 2019 30 Jun 2022
NIHR RfPB_Evaluation of the Care Companion_Variation to contract National Institute for Health Research (NIHR DoH) 01 Oct 2020 02 Apr 2022
NIHR TAR2 12 month extension and supplement - orginal award on IDEATE number 00169 under Aileen Clarke National Institute for Health Research (DoH) 01 Apr 2021 31 Mar 2022
BioImpedance Spectroscopy to Maintain Renal Output: The BISTRO Trial National Institute for Health Research (DoH) 17 Jul 2017 31 Jan 2022
NIHR RfPB Second Stage: PLANES via Liverpool National Institute for Health Research (DoH) 01 Apr 2019 31 Mar 2021